Biobank Aimed to Study Gynecological Pathologies, of Male and Female Infertility and Pregnancy Pathologies

NCT ID: NCT07265908

Last Updated: 2025-12-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ENROLLING_BY_INVITATION

Total Enrollment

3000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-04-09

Study Completion Date

2043-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The REPRO-Biobank has been established at San Raffaele Hospital in Milan for the purpose of collecting and preserving human biological samples and associated data. Its primary objective is to support biomedical research, with a particular focus on advancing scientific knowledge - including in the field of genetics - related to gynecological disorders, male and female infertility, and pregnancy-related conditions.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gynecological Disorders Male Infertility Female Infertility Pregnancy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Affected participants

Subjects diagnosed with gynecological disorders, male or female infertility, or pregnancy-associated conditions.

Blood sampling

Intervention Type OTHER

Blood sampling

Healthy participants

Subjects without a diagnosis of gynecological disorders, male or female infertility, or pregnancy-associated conditions.

Blood sampling

Intervention Type OTHER

Blood sampling

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Blood sampling

Blood sampling

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male infertility
* Female infertility
* Gynecological disorders
* Pregnancy-related conditions
* Conditions requiring fertility preservation treatment (oocyte cryopreservation, ovarian tissue preservation)
* Informed consent signed by the adult patient or by the parents/legal guardians of pediatric patients


* Healthy adult subjects (including pregnant and lactating women)
* Able to give informed consent for participation in the study

Exclusion Criteria

* Patients unable or unwilling to sign the informed consent

* Patients unable or unwilling to sign the informed consent
Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

IRCCS San Raffaele

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Enrico Papaleo

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Enrico Papaleo, MD

Role: PRINCIPAL_INVESTIGATOR

IRCCS San Raffaele

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Irccs San Raffaele Hospital

Milan, Milan, Italy

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Italy

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

REPRO-Biobank

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Adenomyosis and ART
NCT05937490 UNKNOWN PHASE4